logo
Introduction
Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study
The North American Experience with Stereotactic Body Radiation Therapy in Non-small Cell Lung Cancer
Surgery for Stage I NSCLC in Japan
A Japan Clinical Oncology Group Trial for Stereotactic Body Radiation Therapy of Non-Small Cell Lung Cancer
Radiographic Response and Clinical Toxicity Following SBRT for Stage I Lung Cancer
Adjuvant Chemotherapy of Stage I Non-small Cell Lung Cancer in North America
Molecular Pathogenesis of Early-Stage Non-small Cell Lung Cancer and a Proposal for Tissue Banking to Facilitate Identification of New Biomarkers
Grant Award Announcement